GASTROINTESTINAL BACTERIAL OVERGROWTH

This adverse event was reported 600 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL BACTERIAL OVERGROWTH:

# Drug Count
0 RIFAXIMIN 113
1 ADALIMUMAB 45
2 ERGOCALCIFEROL 41
3 INFLIXIMAB 39
4 PANTOPRAZOLE 38
5 VEDOLIZUMAB 37
6 LEVOTHYROXINE SODIUM 36
7 OMEPRAZOLE MAGNESIUM 36
8 ACETAMINOPHEN 35
9 OMEPRAZOLE 30
See all common drugs associated with GASTROINTESTINAL BACTERIAL OVERGROWTH

GASTROINTESTINAL BACTERIAL OVERGROWTH is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 8 0.0039
1 Rifamycin Antibacterial [EPC] 114 0.0031
2 GLP-2 Analog [EPC] 27 0.0020
3 Provitamin D2 Compound [EPC] 41 0.0014
4 Macrolide Antibacterial [EPC] 1 0.0010
5 Methylating Agent [EPC] 1 0.0010
6 Human Immunoglobulin G [EPC] 15 0.0007
7 Integrin Receptor Antagonist [EPC] 38 0.0004
8 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
9 Lipid Emulsion [EPC] 1 0.0004
See all drug classes enriched for association with GASTROINTESTINAL BACTERIAL OVERGROWTH